IZO:CC - Izotropic Announces Investor Conference Schedule
(TheNewswire)
VANCOUVER, BC – TheNewswire - April 12, 2022 – Izotropic Corporation (“ Izotropic ” or the “ Company ”)(CSE: IZO ) (CNSX: IZO .CN) (OTC: IZOZF ) (FSE: 1R3 ), a companycommercializing a dedicated breast CT (computed tomography) imagingplatform, IzoView, for the more accurate detection and diagnosis ofbreast cancers, announces the Company’sattendance at the following investor conferences:
-
NobleCon18
Date: April 19 - 21, 2022
Location: Miami, FL -
Strategic Investment Insights
Date: May 6 th 7 th , 2022
Location: Chicago, IL -
Virtual Investor Conferences: LifeSciences Investor Forum
Date: June 23, 2022
Location: Virtual
About Noblecon:
Nobelcon is presented by Noble Capital Markets (“Noble”) is aresearch driven investment bank that has supported small µcap companies since 1984. As a FINRA andSEC licensed broker dealer Noble provides institutional-quality equityresearch, merchant and investment banking, and order executionservices. In 2005, Noble established NobleCon , an investor conferencethat has grown substantially over the last decade. Noblelaunched www.channelchek.com in 2018- an investor community dedicated exclusively to public small andmicro-cap companies and their industries. Channelchek is the firstservice to offer institutional-quality research to the public, forFREE at every level without a subscription. More than 6,000 publicemerging growth companies are listed on the site, with growing contentincluding research, webcasts, podcasts, and balanced news.
About Strategic Investment Insights:
Strategic InvestmentInsights offers a unique opportunityto present Izotropic to money managers, institutional buyers, as wellas retail investors. Chicago is one of the leading financial centersin North America and Strategic Investment Insights provides a portalinto this valuable resource. In addition, the conferences vast virtualnetwork exposes Exhibitors to potential shareholders from across NorthAmerica.
About Virtual Investor Conferences:
Hosted by OTC Markets, Virtual InvestorConferences is the leadingproprietary investor conference series that provides an interactiveforum for publicly traded companies toseamlessly present directly to investors. Providing a real-time investor engagement solution, VIC isspecifically designed to offer companies more efficient investoraccess. Replicating the components of an on-site investor conference,VIC offers companies enhanced capabilities to connect with investors,schedule targeted one-on-one meetings and enhance their presentationswith dynamic video content. Accelerating the next level of investorengagement, Virtual Investor Conferences delivers leading investorcommunications to a global network of retail and institutionalinvestors.
ON BEHALF OF THE COMPANY
Dr. John McGraw, CEO
Investor RelationsContact:
James Berard
Email: jberard@izocorp.com
Cell: 778-228-2314
Toll Free: 1-833-IZOCORP ext.1
Media Inquiries Contact:
Jaclyn Thast
Email: jaclyn@izocorp.com
Toll Free: 1-833-IZOCORP ext.3
About Izotropic Corporation
Izotropic Corporation is the only publicly tradedcompany commercializing a dedicated breast CT imaging platform,IzoView, for the more accurate detection and diagnosis of breastcancers. To expedite patient and provider access to IzoView,Izotropic's initial clinical study intends to demonstrate superiorperformance of diagnostic breast CT imaging over diagnosticmammography procedures and will initiate in Q2 2022. In follow-onclinical studies, Izotropic intends to validate platform applications,including breast screening in radiology, treatment planning andmonitoring in surgical oncology, and breast reconstruction and implantmonitoring in plastic and reconstructive surgery.
More information about Izotropic Corporation can befound on its website at izocorp.com and by reviewing its profile on SEDAR at sedar.com.
Forward-Looking Statements
This document may contain statements that are"Forward-Looking Statements," which are based upon thecurrent estimates, assumptions, projections, and expectations of theCompany's management, business, and its knowledge of the relevantmarket and economic environment in which it operates. The Company hastried, where possible, to identify such information and statements byusing words such as "anticipate," "believe,""envision," "estimate," "expect,""intend," "may," "plan,""predict," "project," "target,""potential," "will," "would,""could," "should," "continue,""contemplate" and other similar expressions and derivationsthereof in connection with any discussion of future events, trends orprospects or future operating or financial performance, although notall forward-looking statements contain these identifying words. Thesestatements are not guarantees of performance and involve risks and uncertainties that are difficult to controlor predict, and as such, they may cause future results of theCompany's activity to differ significantly from the content andimplications of such statements. Forward-Looking Statements arepertinent only as of the date on which they are made, and the Companyundertakes no obligation to update or revise any Forward-LookingStatements to reflect new information or the occurrence of futureevents or circumstances unless otherwise required to do so by law.Neither the Company nor its shareholders, officers, and consultantsshall be liable for any action and the results of any action taken byany person based on the information contained herein, includingwithout limitation the purchase or sale of Company securities. Nothingin this document should be deemed to be medical or other advice of anykind. All images are for illustrative purposesonly. IzoView is not yet approved for sale.
Copyright (c) 2022 TheNewswire - All rights reserved.